Evidence map›Paper›PMID 31315781›Full record

ArticleZhongguo fei ai za zhi = Chinese journal of lung cancer2019

[Genetic Mutation Screening of DNA Polymerase in Human Lung Cancer].

Qingjun Wu, Wenxin Tian, Hanbo Yu, Chuan Huang, Peng Jiao, Chao Ma, Yongzhong Wang, Wen Huang, Yaoguang Sun, Bin Ai and 1 more

Open access · greenAbstract read
In one paragraph

Article in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Qingjun WuDepartment of Thoracic Surgery, Beijing Hospital, National Center of Gerontology, 
Beijing 100730, China.
Wenxin TianDepartment of Thoracic Surgery, Beijing Hospital, National Center of Gerontology, 
Beijing 100730, China.
Hanbo YuDepartment of Thoracic Surgery, Beijing Hospital, National Center of Gerontology, 
Beijing 100730, China.
Chuan HuangDepartment of Thoracic Surgery, Beijing Hospital, National Center of Gerontology, 
Beijing 100730, China.
Peng JiaoDepartment of Thoracic Surgery, Beijing Hospital, National Center of Gerontology, 
Beijing 100730, China.
Chao MaDepartment of Thoracic Surgery, Beijing Hospital, National Center of Gerontology, 
Beijing 100730, China.
Yongzhong WangDepartment of Thoracic Surgery, Beijing Hospital, National Center of Gerontology, 
Beijing 100730, China.
Wen HuangDepartment of Thoracic Surgery, Beijing Hospital, National Center of Gerontology, 
Beijing 100730, China.
Yaoguang SunDepartment of Thoracic Surgery, Beijing Hospital, National Center of Gerontology, 
Beijing 100730, China.
Bin AiDepartment of Medical Oncology, Beijing Hospital, National Center of Gerontology, 
Beijing 100730, China.
Hongfeng TongDepartment of Thoracic Surgery, Beijing Hospital, National Center of Gerontology, 
Beijing 100730, China.
Beijing Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDNA polymerase β is one of the key enzymes for DNA repair and it was reported that about 30 percent of different types of cancers carried mutations in its coding gene Polb. However, it is still controversial whether it is true or false because of the small sample size in these studies. In current study, we performed genetic screening of promoter and coding regions of Polb gene in 69 Chinese lung cancer patients using Sanger sequencing method, so as to elucidate real mutation frequency of Polb mutations in Chinese Han population.

methodsSalting out extraction method was used to get the genome DNAs from tumor and normal matched tissues of 69 lung cancer patients. The promoter and 14 coding regions of Polb gene were then amplified using these DNAs as the template. After purification, amplicons were sequenced and aligned to the wild type Polb gene in NCBI database, in order to find out the mutated sites of Polb gene in Chinese lung cancer patients.

resultsIn this study, we totally found only 5 mutated sites in Polb gene. In detail, 3 mutations (-196G>T, -188_-187insCGCCC, -168C>A) were located in the promoter region; 2 mutations (587C>G, 612A>T) were found in coding regions. Specially, mutations of -188_-187insCGCCC and 587C>G (resulting to the amino acid substitution of Thr to Ser at position 196) had never been reported by other groups before. However, all these 5 mutated sites could be detected in both tumor and matched normal tissues, which inferred that they are not lung tumor specific mutations.

conclusionsNo lung tumor specific mutations of Polb gene could be found in Chinese lung cancer patients and Polb gene mutation might not be a molecular marker for Chinese lung cancer patients.

Indexed as

DNA Mutational AnalysisGenetic TestingAgedAged, 80 and overBase SequenceDNA Polymerase betaEarly Detection of CancerExonsFemaleHumansLung NeoplasmsMaleMiddle AgedDNA Polymerase betaPOLB protein, humanDNA polymerase βLung neoplasmsMutation analysisPCR amplification

Identifiers

PMID31315781
PMCPMC6712269
OpenAlexW3003641179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.